We are submitting Monitoring Agency Report for the Quarter ended 30th June 2026.

14th August 2026 The Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001 Scrip Code: 544442 Dear Sir/Madam, Sub: Submission of Monitoring Agency Report for the Quarter ended 30th June 2026. Ref.: Disclosure under Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (“SEBI Listing Regulations”) and Regulation 41 (4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended (“SEBI ICDR Regulations”). Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are submitting herewith the Monitoring Agency Report issued by Brickworks Ratings India Private Limited, for the Quarter ended 30th June 2026, in respect of the utilisation and application of funds raised through the IPO of the Company. Kindly take the above information on record. Thank you. For Chemkart India limited Basavaraj Shankar Dalawai Designation: Chief Financial Officer Enclosed: A/a Monitoring Agency Report for Chemkart India Limited for the quarter ended June 30, 2026 No. BWR/2026-27/IPM/CIL/04 August 14,2026 Mr. Basavaraj Shankar Dalawai Chief Financial O(cid:431)icer Chemkart India Limited O(cid:431)ice No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III, Santacruz (East), Mumbai - 400055, Maharashtra, India Dear Sir, Fourth Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Fresh Issue and O(cid:431)er for Sale of Equity Shares Issue of Chemkart India Limited (“the Company”) Pursuant to Regulation 41 of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”) and Monitoring Agency Engagement Letter dated May 28, 2025, Brickwork Ratings (BWR) has prepared the Fourth Monitoring Agency Report, as per Schedule XI of the SEBI ICDR Regulations towards utilisation of proceeds from the funds raised, for the quarter ended June 30, 2026. The funds raised by the Company were through Fresh Issue and O(cid:431)er for Sale of Equity Shares aggregating to Rs 80.08 Crore of the Company. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated June 20, 2025. Request you to kindly take the same on records. Thanking you, Yours Faithfully, Mr Niraj Kumar Rathi Senior Director, Ratings - Brickwork Ratings Report of the Monitoring Agency (MA) Name of the issuer: Chemkart India Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: Brickwork Ratings India Private Limited (a) Deviation from the objects: No (b) Range of Deviation: NA Declaration: We declare that this report is based on the format prescribed by the SEBI (ICDR) Regulations, 2018, we further declare that this report provides a true and fair view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. We declare that we do not have any direct/indirect interest in or relationship with the issuer/promoters/directors/management and also confirm that we do not perceive any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its a(cid:431)iliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its a(cid:431)iliates may have a credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name of the Authorized Signatory: Mr Niraj Kumar Rathi Designation of Authorized Person/Signing Authority: Senior Director, Ratings, Brickwork Ratings 1) Issuer Details: Name of the issuer: Chemkart India Limited Names of the promoter: Mr. Ankit Shailesh Mehta, Ms. Parul Shailesh Mehta and Mr. Shailesh Vinodrai Mehta Industry / sector to which it belongs: Nutraceuticals 2) Issue Details: Issue period: 7 July 2025 to 9 July 2025 Type of issue (public/ rights): Fresh Issue and O(cid:431)er for Sale of Equity shares Type of specified securities: Equity Shares IPO Grading, if any: Not Applicable Issue size (in ₹ Crore): 80.08 Total Amount Number Value as per Offer Document Particulars Price (₹) Received of (₹ Crore) (₹ Crore) Securities Equity Shares-Fresh Issue 2600000 248 64.48 64.48 Equity Shares-Offer for sale 629200 248 15.60 15.60 Total 3229200 248 80.08 80.08 Note: As per prospectus, the O(cid:431)er for Sale (OFS) amount is Rs.15.60 crore. During the quarter ended September 30, 2025, the company has transferred Rs.13.69 crore to OFS share holder and Rs.2.20 crore issue expenses was incurred by the company related to OFS thus aggregating to Rs.15.89 crore. Accordingly, this has resulted in an additional outflow of Rs 0.29 crore towards the OFS shareholders, over and above the amount specified in the Prospectus. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / Comments Comments certifications of of Particulars Reply considered by Monitoring Board of Monitoring Agency Agency Directors for preparation of report Bank Statements, Whether all utilization is as per Company’s letter, the disclosures in the O(cid:431)er No Nil Nil Invoices, CA Document? Certificate. Whether shareholder approval has been obtained in case of material deviations# from Nil Nil Nil Applicable expenditures disclosed in the O(cid:431)er Document? Whether the means of finance for the disclosed objects of the issue No Nil Nil Nil has changed? Is there any major deviation observed over the earlier Nil Applicable Nil Nil monitoring agency reports? Whether all Government/statutory approvals Yes Company’s letter Nil Nil related to the object(s) have been obtained? Whether all arrangements pertaining to technical Not Nil Nil Nil assistance/collaboration are in Applicable operation? Are there any favorable events improving the viability of these No Company’s letter Nil Nil object(s)? Are there any unfavorable events a(cid:431)ecting the viability of the No Company’s letter Nil Nil object(s)? Is there a [Showing first 8,000 characters — download PDF for full document]